Aldeyra Therapeutics Inc.

BE:137 Germany

Market Cap

$45.22K

€44.05K EUR

Market Cap Rank

#42491 Global

#6645 in Germany

Share Price

€4.42

Change (1 day)

-0.63%

52-Week Range

€1.62 - €6.17

All Time High

€13.20

Aldeyra Therapeutics Inc. - Asset Resilience Ratio

Latest as of June 2024: 39.11%

Aldeyra Therapeutics Inc. (137) has an Asset Resilience Ratio of 39.11% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€49.30 Million

Cash + Short-term Investments

Total Assets

€126.04 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2023)

This chart shows how Aldeyra Therapeutics Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Aldeyra Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€49.30 Million	39.11%
Total Liquid Assets	€49.30 Million	39.11%

Asset Resilience Insights

Very High Liquidity: Aldeyra Therapeutics Inc. maintains exceptional liquid asset reserves at 39.11% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.